Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Gregory Ali

Nurse Practitioner, Acute Care Novi, MI Nurse Practitioner

NPI 1871126813 CMS profile 10660818

26750 Providence Pkwy Ste 120, Novi, MI 48374

Open in the dashboard

General payments

$13,408

529 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gregory Ali of Novi, MI is reported in the CMS Open Payments database as having received $13,408 across 529 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Acute Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,363 212
2024 General $1,101 51
2023 General $2,357 76
2022 General $2,874 84
2021 General $1,714 106

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Ali
  • Nurse Practitioner, Acute Care median
  • Middle half of Nurse Practitioner, Acute Care
  • National median

In program year 2025, general payments to Gregory Ali were reported at $5,363. Among 11,827 Nurse Practitioner, Acute Care profiles paid that year, the median was $152 and the middle half received between $48 and $458.

Show as a table
Year Gregory Ali Nurse Practitioner, Acute Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,714 $123 $38–$327 $132
2022 $2,874 $130 $44–$369 $149
2023 $2,357 $144 $49–$410 $160
2024 $1,101 $146 $48–$433 $164
2025 $5,363 $152 $48–$458 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,749 144 payments
  2. Nalu Medical, Inc. $1,233 9 payments
  3. Nevro Corp. $1,089 12 payments
  4. Teva Pharmaceuticals USA, Inc. $1,058 21 payments
  5. Boston Scientific Corporation $780 26 payments
  6. Collegium Pharmaceutical, Inc. $679 43 payments
  7. Scilex Pharmaceuticals Inc. $565 27 payments
  8. EMD Serono, Inc. $468 14 payments
  9. Medtronic, Inc. $391 14 payments
  10. Axsome Therapeutics, Inc. $387 9 payments
  11. Other $5,009 210 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $11,824 517 payments
  2. Travel and Lodging $1,259 7 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $270 4 payments
  4. Education $56 1 payment
Products named General payments · program years 2021–2025
  1. RELISTOR $1,635 136 payments
  2. Nalu Neurostimulation System $1,233 9 payments
  3. WaveWriter Alpha Prime 16 $747 24 payments
  4. Austedo XR $683 16 payments
  5. Senza Spinal Cord Stimulator $558 5 payments
  6. XTAMPZA $530 36 payments
  7. ZTLido $459 22 payments
  8. Symbravo $387 9 payments
  9. Senza Spinal Cord Stimulator $357 5 payments
  10. BRIUMVI $306 8 payments
  11. Other $6,693 280 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

529 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Acute Care in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record